ArticleFrontiers in neurology2025
CTA and DTI combined with robot-assisted puncture external drainage improves clinical efficacy for mild basal ganglia haematoma.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Robot-assisted puncture and drainage have been increasingly popular as surgical interventions for moderate basal ganglia hematomas; nevertheless, there is scant clinical evidence of their effectiveness in patients with mild basal ganglia hematomas (hematoma volume ≤ 15 mL). This study examined the safety and efficacy of CTA and DTI combined with robot-assisted puncture and drainage for mild basal ganglia hematomas. Methods: We analyzed the clinical data (general information, short-term efficacy, and long-term efficacy) of 104 patients with mild cerebral hematoma, of whom 62 opted for medicinal conservative treatment (control group) and 42 opted for CTA and DTI combined with robot-assisted puncture drainage (experimental group). Results: Compared with the control group, patients in the experimental group had a shorter hospital stay, a lower incidence of pulmonary infections, and a significantly lower frequency of antibiotics and mannitol within 3 days after surgery. In addition, patients in the experimental group had a significantly lower amount of residual hematoma within 3 days after surgery, which was completely resolved after 7 days, significantly shorter than the average hematoma subsidence time of 21 days in the control group. The clinical efficacy of the experimental group was better than those of the control group at 30 days, 3 months and 1 year. Conclusion: The management of mild basal ganglia hematomas by CTA and DTI combined with robot-assisted puncture drainage holds significant potential for clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.